![]() Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation. | ![]() Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS. | ||
Founding Date | Founding Date 2016 | Founding Date 2007 | Founding Date 2002 |
Type | Type Private | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ | Locations Maple Grove, US HQ | Locations New York, US HQ |
Employees | Employees 8 | Employees 10 | Employees 330352% increase |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 35m | Total funding raised $ 225.3m |

Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.
View company
Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
View company